_id
691b16a93c536f8df2318bc2
Ticker
MLBON.PA
Name
Bonyf NV
Exchange
PA
Address
Kalvekeetdijk 179, Knokke-Heist, Belgium, 8300
Country
France
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
EUR
Website
https://bonyf.com
Description
bonyf N.V. engages in the research, development, production, and distribution of oral and dental products in Belgium and internationally. The company offers PerioTabs, a brushing solution for gums, teeth, and dental implants to help reduce gingivitis, periodontitis, peri-mucositis, and peri-implantitis; and AphtoFix, a film-forming cream for the local treatment of mouth ulcers. It also provides denture care products, such as OlivaFix denture adhesive creams and NitrAdine disinfecting denture tabs; Denture Repair-fix, an instant repair system for broken or cracked dentures and teeth detached from dentures; Fixobridge, a ready to use cement that fixes dislodged crowns, inlays, and bridges; denture relining cushion for ill-fitting dentures; Effervescent denture cleanser tablets; Superior denture adhesive creams; and Cavifix, a synthetic resin-based filling material to temporarily seal newly formed cavities and repair lost fillings or inlays. In addition, the company offers orthodontic care products, including NitrAdine Ortho & Junior disinfecting tabs to clean and disinfect removable orthodontic appliances; and wound care products comprising HeelFix and FingerFix paste dressing products for cracks and chapped skin on feet and hands. bonyf N.V. was incorporated in 1979 and is headquartered in Knokke-Heist, Belgium.
Last Close
4.9
Volume
10
Current Price
4.9
Change
-0.5
Last Updated
2025-12-31T15:57:56.567Z
Image
https://logo.clearbit.com/bonyf.com
Ipo Date
-
Market Cap
3178440
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2021-03-31
Revenue
789432
Cost Of Revenue
-
Gross Profit
789432
Operating Expenses
-
Operating Income
789432
Interest Expense
-
Pretax Income
789432
Net Income
789432
Eps
1.341202854230377
Dividends Per Share
-
Shares Outstanding
588600
Income Tax Expense
-55213
EBITDA
789432
Operating Margin
100
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
58741
Property Plant Equipment
-
Total Assets
58741
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
58741
Equity
-
Bs_currency_symbol
EUR
Depreciation
55213
Change In Working Capital
-
Cash From Operations
236514
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
236514
Cf_currency_symbol
EUR
PE
-
PB
-
ROE
-
ROA
1343.9199196472653
FCF
236514
Fcf Percent
0.29960021889155747
Piotroski FScore
2
Health Score
70
Deep Value Investing Score
4.5
Defensive Investing Score
2
Dividend Investing Score
3
Economic Moat Investing Score
5.5
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
1
Net Net Investing Score
1.5
Quality Investing Score
4
Value Investing Score
3
Quarters > 0 > quarter
2021-03-31
Quarters > 0 > income Statement > revenue
789432
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
789432
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
789432
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
789432
Quarters > 0 > income Statement > net Income
789432
Quarters > 0 > income Statement > eps
1.341202854230377
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
588600
Quarters > 0 > income Statement > income Tax Expense
-55213
Quarters > 0 > income Statement > EBITDA
789432
Quarters > 0 > income Statement > operating Margin
100
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
58741
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
58741
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
58741
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
55213
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
236514
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
236514
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
1.341202854230377
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
1343.9199196472653
Quarters > 0 > ratios > FCF
236514
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.29960021889155747
Quarters > 0 > health Score
70
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
281483
Annuals > 0 > income Statement > cost Of Revenue
258907
Annuals > 0 > income Statement > gross Profit
22575
Annuals > 0 > income Statement > operating Expenses
57288
Annuals > 0 > income Statement > operating Income
-34713
Annuals > 0 > income Statement > interest Expense
2777.7
Annuals > 0 > income Statement > pretax Income
-36509
Annuals > 0 > income Statement > net Income
-36509
Annuals > 0 > income Statement > eps
-0.06202684335711859
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
588600
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-33732
Annuals > 0 > income Statement > operating Margin
-12.332183471115485
Annuals > 0 > income Statement > total Other Income Expense Net
-1796
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
5029
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
315994
Annuals > 0 > balance Sheet > inventories
19872
Annuals > 0 > balance Sheet > total Current Assets
340897
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
3340897
Annuals > 0 > balance Sheet > payables
311696
Annuals > 0 > balance Sheet > short Term Debt
35965
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
696484
Annuals > 0 > balance Sheet > equity
2644412
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-36509.91
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.06202684335711859
Annuals > 0 > ratios > PB
1.0906545576105389
Annuals > 0 > ratios > ROE
-1.380609375543599
Annuals > 0 > ratios > ROA
-1.0927903494181352
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
42
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
309374
Annuals > 1 > income Statement > cost Of Revenue
282960
Annuals > 1 > income Statement > gross Profit
26414
Annuals > 1 > income Statement > operating Expenses
66308
Annuals > 1 > income Statement > operating Income
-39894.09
Annuals > 1 > income Statement > interest Expense
1004811
Annuals > 1 > income Statement > pretax Income
-1044705.38
Annuals > 1 > income Statement > net Income
-1044705.38
Annuals > 1 > income Statement > eps
-1.7748987088005437
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
588600
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-39894.09
Annuals > 1 > income Statement > operating Margin
-12.89510107507418
Annuals > 1 > income Statement > total Other Income Expense Net
-1004811.29
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
9958.61
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0.39
Annuals > 1 > balance Sheet > inventories
37331
Annuals > 1 > balance Sheet > total Current Assets
92858
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
3092858
Annuals > 1 > balance Sheet > payables
299565
Annuals > 1 > balance Sheet > short Term Debt
75000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
411936
Annuals > 1 > balance Sheet > equity
2680922
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-1044705.38
Annuals > 1 > cash Flow > depreciation
-140.87
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.7748987088005437
Annuals > 1 > ratios > PB
1.0758015339498874
Annuals > 1 > ratios > ROE
-38.96813782721019
Annuals > 1 > ratios > ROA
-33.77799368739205
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
42
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
277397
Annuals > 2 > income Statement > cost Of Revenue
267349
Annuals > 2 > income Statement > gross Profit
10048
Annuals > 2 > income Statement > operating Expenses
327558
Annuals > 2 > income Statement > operating Income
-317510.41
Annuals > 2 > income Statement > interest Expense
3000552
Annuals > 2 > income Statement > pretax Income
-3318063.1
Annuals > 2 > income Statement > net Income
-3318063.1
Annuals > 2 > income Statement > eps
-5.637212198436969
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
588600
Annuals > 2 > income Statement > income Tax Expense
0.99
Annuals > 2 > income Statement > EBITDA
-267475.42
Annuals > 2 > income Statement > operating Margin
-114.46065025937556
Annuals > 2 > income Statement > total Other Income Expense Net
-3000552.69
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
393.08
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
129816.99
Annuals > 2 > balance Sheet > inventories
23811
Annuals > 2 > balance Sheet > total Current Assets
170599
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
4170599
Annuals > 2 > balance Sheet > payables
364657
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
444971
Annuals > 2 > balance Sheet > equity
3725628
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-3318063.1
Annuals > 2 > cash Flow > depreciation
50034
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-5.637212198436969
Annuals > 2 > ratios > PB
0.7741352598810188
Annuals > 2 > ratios > ROE
-89.06050469880515
Annuals > 2 > ratios > ROA
-79.5584303357863
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
41
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
2372336
Annuals > 3 > income Statement > cost Of Revenue
715244
Annuals > 3 > income Statement > gross Profit
1657092
Annuals > 3 > income Statement > operating Expenses
1705856
Annuals > 3 > income Statement > operating Income
-48887
Annuals > 3 > income Statement > interest Expense
18220
Annuals > 3 > income Statement > pretax Income
-67107
Annuals > 3 > income Statement > net Income
-70176
Annuals > 3 > income Statement > eps
-0.11922528032619775
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
588600
Annuals > 3 > income Statement > income Tax Expense
3069
Annuals > 3 > income Statement > EBITDA
3861
Annuals > 3 > income Statement > operating Margin
-2.0607114675155627
Annuals > 3 > income Statement > total Other Income Expense Net
-18220
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
50466
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
513447
Annuals > 3 > balance Sheet > inventories
499284
Annuals > 3 > balance Sheet > total Current Assets
1076813
Annuals > 3 > balance Sheet > property Plant Equipment
224676
Annuals > 3 > balance Sheet > total Assets
1379545
Annuals > 3 > balance Sheet > payables
228427
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
267667
Annuals > 3 > balance Sheet > total Liabilities
1099482
Annuals > 3 > balance Sheet > equity
280063
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-70176
Annuals > 3 > cash Flow > depreciation
52748
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
56954782
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
56954782
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.11922528032619775
Annuals > 3 > ratios > PB
10.298182908845511
Annuals > 3 > ratios > ROE
-25.057219268521724
Annuals > 3 > ratios > ROA
-5.086894592057526
Annuals > 3 > ratios > FCF
56954782
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
24.007890113373485
Annuals > 3 > health Score
28
Valuation > metrics > PE
1.341202854230377
Valuation > final Score
70
Valuation > verdict
86.6% Undervalued
Profitability > metrics > ROA
1343.9199196472653
Profitability > metrics > Net Margin
1
Profitability > final Score
80
Profitability > verdict
Adequate
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
0
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
0
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T23:10:13.151Z
bonyf N.V. engages in the research, development, production, and distribution of oral and dental products in Belgium and internationally. The company offers PerioTabs, a brushing solution for gums, teeth, and dental implants to help reduce gingivitis, periodontitis, peri-mucositis, and peri-implantitis; and AphtoFix, a film-forming cream for the local treatment of mouth ulcers. It also provides denture care products, such as OlivaFix denture adhesive creams and NitrAdine disinfecting denture tabs; Denture Repair-fix, an instant repair system for broken or cracked dentures and teeth detached from dentures; Fixobridge, a ready to use cement that fixes dislodged crowns, inlays, and bridges; denture relining cushion for ill-fitting dentures; Effervescent denture cleanser tablets; Superior denture adhesive creams; and Cavifix, a synthetic resin-based filling material to temporarily seal newly formed cavities and repair lost fillings or inlays. In addition, the company offers orthodontic care products, including NitrAdine Ortho & Junior disinfecting tabs to clean and disinfect removable orthodontic appliances; and wound care products comprising HeelFix and FingerFix paste dressing products for cracks and chapped skin on feet and hands. bonyf N.V. was incorporated in 1979 and is headquartered in Knokke-Heist, Belgium.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A€4.90 low for MLBON.PA bonyf N.V. EURONEXT 21 Jan 2026: Oversold bounce trade idea - Meyka
1/21/2026
€4.90 low for MLBON.PA bonyf N.V. EURONEXT 21 Jan 2026: Oversold bounce trade idea Meyka
Read more →(Last Updated 2021-03-31)
Health Score
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Bonyf NV
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2021-03-31)
(Last Updated 2021-03-31)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2021-03-31)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2021-03-31)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.